SCHEDULE: FMR LLC Maintains 2.2% Stake in Astria Therapeutics
Beneficial Ownership Report
FMR LLC and Abigail P. Johnson report a 2.2% beneficial ownership of Astria Therapeutics Inc. common stock as of October 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 1,251,766.05 shares of Astria Therapeutics Inc. common stock.
- This ownership represents 2.2% of the company's total outstanding common stock.
- FMR LLC holds sole voting power over 1,249,373.00 shares and sole dispositive power over 1,251,766.05 shares.
- Abigail P. Johnson, as a Director, Chairman, and Chief Executive Officer of FMR LLC, is deemed to beneficially own the same 1,251,766.05 shares due to the Johnson family's controlling interest in FMR LLC.
- This filing is an Amendment No. 8 to a Schedule 13G, indicating a routine update to a previously reported beneficial ownership stake.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine regulatory filing disclosing beneficial ownership and does not contain operational or financial performance updates that would typically influence sentiment.
Positives
- A significant institutional investor, FMR LLC, continues to hold a stake in Astria Therapeutics Inc., indicating ongoing interest in the company.
Negatives
- The reported beneficial ownership of 2.2% is below the 5% threshold, suggesting it is not a controlling or highly influential stake in the company.
Risks
- No specific risks related to Astria Therapeutics Inc.'s operations, financial health, or strategic direction are disclosed in this beneficial ownership filing.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding Astria Therapeutics Inc.'s future performance, operational plans, or strategic direction.
Industry Context
This filing is a routine regulatory disclosure of institutional ownership and does not provide specific insights into broader industry trends, competitive landscape, or Astria Therapeutics Inc.'s position within its sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding the continued beneficial ownership stake held by a significant institutional investor, FMR LLC.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC, as referenced in the signature. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC where the Power of Attorney was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson, as referenced in the signature. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2025-10-31 | Date of event which requires the filing of this statement, representing the measurement date for beneficial ownership. |
| 2025-11-06 | Date of filing of this Schedule 13G Amendment No. 8. |
Keywords
Astria Therapeutics, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.